Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID P16615 488 ATP2A2 ATP2B Keratosis follicularis Ubiquitination N K30 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S38 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N S38 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K128 P16615 488 ATP2A2 ATP2B Keratosis follicularis Ubiquitination N K128 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S136 P16615 488 ATP2A2 ATP2B Bladder urothelial carcinoma Ubiquitination N K143 P16615 488 ATP2A2 ATP2B Brain lower grade glioma Ubiquitination N K158 P16615 488 ATP2A2 ATP2B Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K158 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K158 P16615 488 ATP2A2 ATP2B Kidney renal clear cell carcinoma Ubiquitination N K158 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Ubiquitination N K158 P16615 488 ATP2A2 ATP2B Brain lower grade glioma Methylation N R164 P16615 488 ATP2A2 ATP2B Keratosis follicularis Methylation N R164 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Methylation N R164 P16615 488 ATP2A2 ATP2B Keratosis follicularis Ubiquitination N K169 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N S178 P16615 488 ATP2A2 ATP2B Pancreatic adenocarcinoma Phosphorylation N S178 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S184 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N S184 P16615 488 ATP2A2 ATP2B Pancreatic adenocarcinoma Phosphorylation N S184 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S186 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K189 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N T191 P16615 488 ATP2A2 ATP2B Head and neck squamous cell carcinoma Phosphorylation N T191 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N T191 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Ubiquitination N K205 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S210 P16615 488 ATP2A2 ATP2B Darier disease Acetylation N K218 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N T226 P16615 488 ATP2A2 ATP2B Global developmental delay Phosphorylation N T226 P16615 488 ATP2A2 ATP2B Pancreatic adenocarcinoma Phosphorylation N T226 P16615 488 ATP2A2 ATP2B Global developmental delay Phosphorylation N T230 P16615 488 ATP2A2 ATP2B Colon adenocarcinoma Phosphorylation N T242 P16615 488 ATP2A2 ATP2B Colon adenocarcinoma Ubiquitination N K252 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Ubiquitination N K252 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N S261 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Phosphorylation N Y294 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N T345 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N T345 P16615 488 ATP2A2 ATP2B Uterine corpus endometrial carcinoma Phosphorylation N T345 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S346 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N S346 P16615 488 ATP2A2 ATP2B Uterine corpus endometrial carcinoma Phosphorylation N S346 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K352 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Ubiquitination N K352 P16615 488 ATP2A2 ATP2B Uterine corpus endometrial carcinoma Ubiquitination N K352 P16615 488 ATP2A2 ATP2B Thyroid carcinoma Ubiquitination N K400 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N Y407 P16615 488 ATP2A2 ATP2B Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K436 P16615 488 ATP2A2 ATP2B Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N T441 P16615 488 ATP2A2 ATP2B Colon adenocarcinoma Ubiquitination N K451 P16615 488 ATP2A2 ATP2B Hepatocellular carcinoma SUMOylation N K480 P16615 488 ATP2A2 ATP2B Hepatocellular carcinoma Acetylation N K481 P16615 488 ATP2A2 ATP2B Hepatocellular carcinoma Ubiquitination N K481 P16615 488 ATP2A2 ATP2B Hepatocellular carcinoma Phosphorylation N T484 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N T484 P16615 488 ATP2A2 ATP2B Hepatocellular carcinoma Phosphorylation N S488 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N S488 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K492 P16615 488 ATP2A2 ATP2B Hepatocellular carcinoma Ubiquitination N K492 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Ubiquitination N K492 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S495 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N Y497 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N Y497 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N T499 P16615 488 ATP2A2 ATP2B Urinary bladder cancer Phosphorylation N S531 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N S538 P16615 488 ATP2A2 ATP2B Keratosis follicularis Ubiquitination N K541 P16615 488 ATP2A2 ATP2B Keratosis follicularis Ubiquitination N K543 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N S546 P16615 488 ATP2A2 ATP2B Keratosis follicularis Methylation N R549 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N S553 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S555 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N S555 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N T557 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N T557 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Phosphorylation N T557 P16615 488 ATP2A2 ATP2B Breast invasive carcinoma SUMOylation N K585 P16615 488 ATP2A2 ATP2B Darier disease SUMOylation N K585 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N S608 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Phosphorylation N S608 P16615 488 ATP2A2 ATP2B Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N T624 P16615 488 ATP2A2 ATP2B Colon adenocarcinoma Phosphorylation N T624 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N T624 P16615 488 ATP2A2 ATP2B Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K628 P16615 488 ATP2A2 ATP2B Colon adenocarcinoma Ubiquitination N K628 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K628 P16615 488 ATP2A2 ATP2B Lung adenocarcinoma Phosphorylation N S663 P16615 488 ATP2A2 ATP2B Bladder urothelial carcinoma Ubiquitination N K683 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K683 P16615 488 ATP2A2 ATP2B Keratosis follicularis Ubiquitination N K683 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Ubiquitination N K683 P16615 488 ATP2A2 ATP2B Darier disease Ubiquitination N K685 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S692 P16615 488 ATP2A2 ATP2B Keratosis follicularis Phosphorylation N S692 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Phosphorylation N S692 P16615 488 ATP2A2 ATP2B Bladder urothelial carcinoma Ubiquitination N K711 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S740 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N T741 P16615 488 ATP2A2 ATP2B Lung squamous cell carcinoma Acetylation N K757 P16615 488 ATP2A2 ATP2B Lung squamous cell carcinoma Ubiquitination N K757 P16615 488 ATP2A2 ATP2B Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S829 P16615 488 ATP2A2 ATP2B Colon adenocarcinoma Phosphorylation N S829 P16615 488 ATP2A2 ATP2B Skin cutaneous melanoma Phosphorylation N S829 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N Y836 P16615 488 ATP2A2 ATP2B Darier disease Phosphorylation N S973 P16615 488 ATP2A2 ATP2B Chronic hypoxic pulmonary hypertension lung tissue Serotonylation U 32116663 P16615 488 ATP2A2 ATP2B Pathological cardiac hypertrophy cardiomyocytes Deubiquitination D 36722348 P16615 488 ATP2A2 ATP2B Hepatocellular carcinoma tumor tissue Tyrosine phosphorylation U Y990 37719369 P16615 488 ATP2A2 ATP2B Heart failure Acetylation U K492 30786847 P16615 488 ATP2A2 ATP2B Heart failure Deacetylation D K492 30786847 P16615 488 ATP2A2 ATP2B Cardiomyopathy SUMOylation D K480 21900893 P16615 488 ATP2A2 ATP2B Cardiomyopathy SUMOylation D K585 21900893